RAPROS (Beraprost Sodium) - Vasodilator Support for CKD
- In stock, ready to ship
- Worldwide Shipping
- Fast Delivery (In 8-15 Days)
- 14-Days Money Back
- Secure Checkout
Pairs well with
Slow CKD Progression & Restore Your Cat's Quality of Life
A diagnosis of chronic kidney disease (CKD) doesn't have to mean watching your cat slowly fade. RAPROS (Beraprost Sodium) is a veterinary-grade prostacyclin analogue that goes beyond symptom management — it targets the root causes of renal deterioration to protect your cat's kidneys and bring back their energy and appetite.
Why Choose RAPROS?
- Improves kidney blood flow — dilates constricted renal blood vessels, delivering vital oxygen and nutrients to damaged tissue
- Reduces tissue scarring — actively combats tubulointerstitial fibrosis, the primary driver of permanent kidney damage
- Protects delicate vessels — preserves capillary structures and prevents microscopic clot formation inside the kidneys
- Restores vitality — clinical trials show noticeable improvements in appetite, weight maintenance, and daily energy within the first few weeks
- Targets IRIS Stage 2–3 CKD — specifically engineered for cats at the critical stages where intervention makes the greatest difference
How It Works
RAPROS is an oral prostacyclin (PGI2) analogue that reduces intraglomerular pressure and improves microcirculation in the kidneys. By breaking the cycle of chronic hypoxia and fibrosis, it actively slows the progression of renal damage rather than simply managing its symptoms.
Product Specifications
- Active Ingredient: Beraprost Sodium 55 μg per tablet
- Pack Size: 100 tablets
- Tablet Size: Ultra-small 6.0 mm diameter — easy to administer
- Dosage: 1 tablet twice daily, given orally after feeding
- Storage: Store at 1°C–30°C in a cool, dry place away from direct sunlight
Recommended Use
For cats diagnosed with IRIS Stage 2 or 3 Chronic Kidney Disease. Always administer after meals to maximize absorption and minimize gastric upset. Use under veterinary supervision as part of a comprehensive CKD management plan.